|
The Cancer Industry Discovers Laetrile
Advertisement
|
In September 2000 The BBC broadcast the following news:
Cyanide targets cancer
By BBC News Online's Jonathan Amos, 7 September 2000
Scientists are using cyanide to attack tumours.
They have tested a two-stage drug that harnesses the power of the dangerous
chemical to kill bowel cancer cells in the lab.
The researchers, at Imperial College, London, now hope to refine the technology
and test it on patients.
The technique takes a lead from some plants that release cyanide to protect
themselves from insect attack.
Tumour specific
The cassava plant, almond tree and hydrangea, all have an enzyme that will
produce cyanide when it comes into contact with a particular sugar molecule.
The enzyme and the sugar are normally kept apart and are only brought together
when a pest bites into the plant tissue.
The Imperial College scientists have engineered the enzyme and attached it to
an antibody that will target specific tumours, when injected into the body.
A second drug, containing the sugar, would then be introduced which would react
with the enzyme to release cyanide and kill the cancer cells.
No resistance
Dr Mahendra Deonarain said the system would be so specific that only the target
tumour would be exposed to the cyanide.
"The enzyme will circulate around the body and accumulate in the tumour only,
and then it will clear from everywhere else. Then the second step is to inject
the sugar drug and that itself will circulate around the body but only where
the tumour is, where the enzyme is, will you get the cyanide.
"It will be enough to kill the cancer cells and you will be able to repeat it
over and over again until the tumour has gone."
Dr Deonarain said the cancer cells would not be able to develop resistance to
the cyanide in the way they can with some of current cancer therapies.
|
Laetrile
What these researchers have done is 'discover' laetrile -- a cancer treatment
pioneered in 1950 by Dr Ernst T Krebs jr and used successfully by him in
partnership with H H Beard in the middle of the 20th century.
Laetrile is still a very well-known treatment which has had great success in
unconventional cancer circles. It was suppressed vigorously by the medical
profession. One practitioner, Jimmy Keller, reckoned on an 80% success rate if
the cancer patient had not had chemotherapy, and 60% if he had. This is far,
far better than anything that conventional medicine can achieve. Unfortunately,
Keller was not a doctor, and only doctors are allowed to treat cancer in the
USA, so he was sentenced to 20 years imprisonment for curing people. Hundreds
of people who had been cured by Keller lobbied the judge in 1997 and Keller's
sentence was reduced to 2 years suspended, on condition that he stopped curing
cancers. He came out of prison in January 1998. However, many cancer patients,
who had not been helped by conventional medicine, came to him to be cured. A
kind and humane man, Keller hadn't the heart to turn them away so the
authorities locked him up again. In the USA curing people is a heinous crime.
Laetrile is a compound, amygdalin, which contains cyanide. It is found in fruit
pits, particularly of apricots. This 'new discovery' is that linamarin, found
in cassava, hydrangea, etcetera, is a similar cyanide-bearing compound.
As this compound is 'new', no doubt they can patent it and make a lot of money
out of what they have derided as quackery for so long.
But the linamarin substance is not as effective as amygdalin - laetrile.
To find more about laetrile, just enter the word into a search engine. World
Without Cancer's website is a good place to start.
How Laetrile works
Laetrile (amygdalin) is a simple compound found most abundantly in the seeds of
non-citrus fruits. Most commercially prepared laetrile is extracted from
apricot seeds. Laetrile is composed of two molecules of glucose (sugar), one
molecule of benzaldehyde (an analgesic) and one molecule of hydrocyanic acid (a
cell-killing compound). It is the hydrocyanic acid which kills cancer cells.
Laetrile's action relies on a chemical difference between normal cells and
cancer cells:
-
Cancer cells contain in abundance an enzyme called beta-glucosidase; normal
cells have very little of it.
-
Normal cells have large quantities of another enzyme called rhodanese; cancer
cells are deficient in that.
Laetrile is broken down into its component parts as a result of the action of
beta-glucosidase. As normal cells are deficient in this, most of the cyanide is
released only in cancer cells. With nothing to control it, the cyanide released
destroys the cancer cells.
In normal body tissue, deficient in beta-glucosidase, very little cyanide is
released and rhodanese, in the presence of sulphur-bearing compounds, converts
the little free cyanide which may be released to thiocyanate which is not
toxic. This thiocyanate is then excreted in the urine. In this way normal cells
survive unharmed.
The cancer industry has been searching for decades for a 'magic bullet', a
treatment which targets only cancer cells without damaging normal cells, and
there it was all the time and they refused to acknowledge it.
Last updated 14 December 2000
|
"A great book that shatters so many of the nutritional fantasies and fads of the last twenty years. Read it and prolong your life."
Clarissa Dickson Wright
"NH&WL may be the best non-technical book on diet ever written"
Joel Kauffman, PhD, Professor Emeritus, University of the Sciences, Philadelphia, PA
- a completely new kind of video and DVD.
"Must be regarded as essential reading . . . informative and thought-provoking." Dr Vyvyan Howard, MB. ChB. PhD. FRCPath. University of Liverpool.
|
